Navigation Links
Astellas to Drive PGA TOUR's New Women's Initiative
Date:2/19/2013

PONTE VEDRA BEACH, Fla., and NORTHBROOK, Ill., Feb. 19, 2013 /PRNewswire/ -- The PGA TOUR and Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today a 3-year agreement in which Astellas will champion the PGA TOUR's commitment to its new Women's Initiative.

"The Women's Initiative is an innovative platform designed to enhance the tournament experience for women and engage women in a meaningful and productive way in our tournament markets," said PGA TOUR Commissioner Tim Finchem . "As a leading pharmaceutical company strongly committed to enhancing health, particularly in the area of urological wellness, Astellas is an ideal partner to help drive our Women's Initiative and connect with women in settings they are already seeking out. We are delighted to collaborate with Astellas on this important and exciting venture."

The Women's Initiative is designed to provide women with information that promotes their overall well-being. Astellas and the PGA TOUR are working together to inform women about important health and wellness issues, encourage discussion on those topics and create opportunities to talk and learn about them.

"Astellas is proud to be partnering with the PGA TOUR on the Women's Initiative, which aims to help women obtain meaningful health-related and general wellness information," said Masao Yoshida , President and CEO, Astellas Pharma US, Inc. "The PGA TOUR's commitment to enhancing health and wellness aligns well with the Astellas focus on empowering and encouraging dialogue about the health and wellness issues that are not discussed often, such as overactive bladder, which affects more than 46 million adults in the U.S."

Key components of the Astellas Women's Initiative will include:

  • Astellas Presents Executive Women's Day—an expansion of the PGA TOUR's current Women's Day program that invites female business leaders from the community to attend a day-long forum focusing on professional, health-related and personal development discussions. Components include high-profile panelists, topic-specific breakout sessions, a keynote speaker and networking opportunities.
  • Astellas Pavilion—an onsite experience and meeting place for tournament participants to engage and learn about wellness issues. These special "women-friendly" facilities will provide information and education.

These 2013 TOUR season components will span 17 tournaments, beginning with the first Astellas Presents Executive Women's Day event on Feb. 26 at The Honda Classic Tournament in Palm Beach Gardens, Fla.

"We are very excited to embrace the new PGA TOUR Women's Initiative and thank Astellas for supporting this innovative program that will invite and attract new attendees to our events while educating them on their health and well-being," said Clair Petersen , tournament director of the John Deere Classic and chairman of the PGA TOUR Tournament Advisory Council.

About Astellas
Astellas Pharma US, Inc., located in Northbrook, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. For more information about Astellas Pharma US, Inc., please visit our website at www.astellas.us.   

The Astellas culture and brand is committed to building community, helping others, encouraging integrity and inspiring people to make a difference, today, tomorrow and every day.

About PGA TOUR
The PGA TOUR is the world's premier membership organization for touring professional golfers, co-sanctioning more than 100 tournaments on the PGA TOUR, Champions Tour, Web.com Tour, PGA TOUR Latinoamerica and PGA TOUR Canada.

The PGA TOUR's mission is to entertain and inspire its fans, deliver substantial value to its partners, create outlets for volunteers to give back, generate significant charitable and economic impact in the communities in which it plays, and provide financial opportunities for TOUR players.

Worldwide, PGA TOUR tournaments are broadcast to nearly 945 million households in 225 countries and territories in 32 languages. Virtually all tournaments are organized as non-profit organizations in order to maximize charitable giving. In 2012, tournaments across all Tours generated more than $122 million for local charitable organizations, bringing the TOUR's all-time total of charitable contributions to more than $1.8 billion.

The PGA TOUR's web site is PGATOUR.com, the No. 1 site in golf, and the organization is headquartered in Ponte Vedra Beach, FL.


'/>"/>
SOURCE Astellas
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
2. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
3. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
4. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
5. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
6. Astellas and Fujita Health University Discover Neuronal Maturation Deficits in Patients Suffering from Schizophrenia and Bipolar Disorder
7. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
8. Physicians Adoption of Velcade for the Treatment of Chronic Graft Versus Host Disease Will Drive Growth In This Market Through 2021
9. The Medical Affairs Function Is a Key Differentiator for Pharma Product Success in Data-Driven Healthcare Market
10. The Expected Approval of Velcade Will Be a Significant Driver of Growth in the Graft Versus Host Disease Drug Market
11. Continued Uptake of Novartis/Incytes Jakafi Will Be the Greatest Driver of Growth in the Myelofibrosis Therapy Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb 24, 2017 ... Committee,s proposal for a new Board of Directors that ... The 2016-2017 Nomination Committee comprises representatives of the company,s ... quarter of 2016 who have accepted a seat on ... The composition of the 2016-2017 Nomination Committee was as ...
(Date:2/23/2017)... -- Visiomed, the French leader in medical grade ... the landscape of healthcare with their innovative use ... solutions. Recognizing the rising demand of self-monitoring alongside ... walls, Visiomed has launched BewellConnect, the most ground-breaking ... that is empowering the lives of patients. ...
(Date:2/23/2017)... 23. Februar 2017 LG Innotek hat heute ... Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der Konkurrenz. ... Bereich zwischen 200 und 280 nm und eignet sich damit ... es ihre DNA zerstört. Das Produkt von LG Innotek ... ...
Breaking Medicine Technology:
(Date:2/24/2017)... Pekin, IL (PRWEB) , ... February 24, 2017 , ... ... in the 7th annual “Imagine Me Beyond What You See” body image mannequin art ... Professional’s Choice will be showcased and the winner revealed at the 31st annual iaedp ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... the Senior International Elite division on February 12th. Ms. Esparza qualified into ... the elite qualifier competition held in Las Vegas, Nevada. Frida is one of ...
(Date:2/23/2017)... ... ... The 89th Academy Awards will be celebrated this weekend, which means it’s ... Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to the shoddiest ... for American Progress (CAP), for its report, Lessons From State Performance on NAEP: Why ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., ... From Not to Hot,” which will begin airing on February 24, 2017. The show ... from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series ...
(Date:2/23/2017)... Angeles, California (PRWEB) , ... February 23, 2017 ... ... Global Sports Development will host a diverse symposium on “Doping in ... of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will be ...
Breaking Medicine News(10 mins):